Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development-Reference-Cited by-同舟云学术

Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development

Published:2003-02 Issue:2 Volume:19 Page:133-144
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Williamson Carolyn¹,Morris Lynn²,Maughan Maureen F.³,Ping Li-Hua⁴,Dryga Sergey A.³,Thomas Robin¹,Reap Elizabeth A.³,Cilliers Tonie²,van Harmelen Joanne¹,Pascual Alvaro⁵,Ramjee Gita⁶,Gray Glenda⁷,Johnston Robert⁸,Karim Salim Abdool⁹,Swanstrom Ronald⁴

Affiliation:

1. Division of Medical Virology, University of Cape Town, Observatory, Cape Town, South Africa 7925

2. National Institute for Communicable Diseases, Sandringham, Johannesburg, South Africa 2131

3. AlphaVax, Research Triangle Park, North Carolina 27709-0307

4. UNC Centre for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7295

5. UNC Centre for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7295 and Permanent address: Department of Microbiology, School of Medicine, Seville, Spain

6. Medical Research Council, Congella, South Africa 4013

7. Perinatal HIV Research Unit, University of Witwatersrand, Witwatersrand, South Africa 2013

8. Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7295

9. University of Natal, Durban, South Africa 4041

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/088922203762688649

Reference31 articles.

1. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?